[logoshowcase center_mode=”true” slides_column=”7″ dots=”false”]
FMBA Files for Registration of “Allergarda,” a Recombinant Vaccine for Birch Pollen Allergy
The vaccine is currently in Phase III clinical trials, evaluating its efficacy against a placebo in patients with allergic rhinitis.
Russia Updates Pharma Licensing: New Timelines and Remote Inspections
The Russian Government has approved a new resolution updating...
GMP-Inspections of veterinary manufacturers in July – October 2025
The review provides available information on the inspection of...
Nanolek Launches Russia’s First Full-Cycle Production of Human Papillomavirus (HPV) Vaccine
The biopharmaceutical company Nanolek, with the support of the...
Session “EAEU’s common market of medicinal products for veterinary use” at the All-Russian GMP Conference 2025
On September 15-17, 2025, the X All-Russian GMP Conference...
FMBA Files for Registration of “Allergarda,” a Recombinant Vaccine for Birch Pollen Allergy
The vaccine is currently in Phase III clinical trials, evaluating its efficacy against a placebo in patients with allergic rhinitis.
Russia Updates Pharma Licensing: New Timelines and Remote Inspections
The Russian Government has approved a new resolution updating...
GMP-Inspections of veterinary manufacturers in July – October 2025
The review provides available information on the inspection of...
Nanolek Launches Russia’s First Full-Cycle Production of Human Papillomavirus (HPV) Vaccine
The biopharmaceutical company Nanolek, with the support of the...
Session “EAEU’s common market of medicinal products for veterinary use” at the All-Russian GMP Conference 2025
On September 15-17, 2025, the X All-Russian GMP Conference...
FMBA Files for Registration of “Allergarda,” a Recombinant Vaccine for Birch Pollen Allergy
The vaccine is currently in Phase III clinical trials, evaluating its efficacy against a placebo in patients with allergic rhinitis.
Russia Updates Pharma Licensing: New Timelines and Remote Inspections
The Russian Government has approved a new resolution updating...
GMP-Inspections of veterinary manufacturers in July – October 2025
The review provides available information on the inspection of...
Nanolek Launches Russia’s First Full-Cycle Production of Human Papillomavirus (HPV) Vaccine
The biopharmaceutical company Nanolek, with the support of the...
Session “EAEU’s common market of medicinal products for veterinary use” at the All-Russian GMP Conference 2025
On September 15-17, 2025, the X All-Russian GMP Conference...
FMBA Files for Registration of “Allergarda,” a Recombinant Vaccine for Birch Pollen Allergy
The vaccine is currently in Phase III clinical trials, evaluating its efficacy against a placebo in patients with allergic rhinitis.
Russia Updates Pharma Licensing: New Timelines and Remote Inspections
The Russian Government has approved a new resolution updating...
GMP-Inspections of veterinary manufacturers in July – October 2025
The review provides available information on the inspection of...
Nanolek Launches Russia’s First Full-Cycle Production of Human Papillomavirus (HPV) Vaccine
The biopharmaceutical company Nanolek, with the support of the...
Session “EAEU’s common market of medicinal products for veterinary use” at the All-Russian GMP Conference 2025
On September 15-17, 2025, the X All-Russian GMP Conference...
FMBA Files for Registration of “Allergarda,” a Recombinant Vaccine for Birch Pollen Allergy
The vaccine is currently in Phase III clinical trials, evaluating its efficacy against a placebo in patients with allergic rhinitis.
Russia Updates Pharma Licensing: New Timelines and Remote Inspections
The Russian Government has approved a new resolution updating...
GMP-Inspections of veterinary manufacturers in July – October 2025
The review provides available information on the inspection of...
Nanolek Launches Russia’s First Full-Cycle Production of Human Papillomavirus (HPV) Vaccine
The biopharmaceutical company Nanolek, with the support of the...
Session “EAEU’s common market of medicinal products for veterinary use” at the All-Russian GMP Conference 2025
On September 15-17, 2025, the X All-Russian GMP Conference...
FMBA Files for Registration of “Allergarda,” a Recombinant Vaccine for Birch Pollen Allergy
The vaccine is currently in Phase III clinical trials, evaluating its efficacy against a placebo in patients with allergic rhinitis.
Russia Updates Pharma Licensing: New Timelines and Remote Inspections
The Russian Government has approved a new resolution updating...
GMP-Inspections of veterinary manufacturers in July – October 2025
The review provides available information on the inspection of...
Nanolek Launches Russia’s First Full-Cycle Production of Human Papillomavirus (HPV) Vaccine
The biopharmaceutical company Nanolek, with the support of the...
Session “EAEU’s common market of medicinal products for veterinary use” at the All-Russian GMP Conference 2025
On September 15-17, 2025, the X All-Russian GMP Conference...
FMBA Files for Registration of “Allergarda,” a Recombinant Vaccine for Birch Pollen Allergy
The vaccine is currently in Phase III clinical trials, evaluating its efficacy against a placebo in patients with allergic rhinitis.
Russia Updates Pharma Licensing: New Timelines and Remote Inspections
The Russian Government has approved a new resolution updating...
GMP-Inspections of veterinary manufacturers in July – October 2025
The review provides available information on the inspection of...
Nanolek Launches Russia’s First Full-Cycle Production of Human Papillomavirus (HPV) Vaccine
The biopharmaceutical company Nanolek, with the support of the...
Session “EAEU’s common market of medicinal products for veterinary use” at the All-Russian GMP Conference 2025
On September 15-17, 2025, the X All-Russian GMP Conference...
FMBA Files for Registration of “Allergarda,” a Recombinant Vaccine for Birch Pollen Allergy
The vaccine is currently in Phase III clinical trials, evaluating its efficacy against a placebo in patients with allergic rhinitis.
Russia Updates Pharma Licensing: New Timelines and Remote Inspections
The Russian Government has approved a new resolution updating...
GMP-Inspections of veterinary manufacturers in July – October 2025
The review provides available information on the inspection of...
Nanolek Launches Russia’s First Full-Cycle Production of Human Papillomavirus (HPV) Vaccine
The biopharmaceutical company Nanolek, with the support of the...
Session “EAEU’s common market of medicinal products for veterinary use” at the All-Russian GMP Conference 2025
On September 15-17, 2025, the X All-Russian GMP Conference...
PHARMPROM is a premier digital resource for the pharmaceutical sector, combining breaking news, deep insights, and key market events. We cover the entire product lifecycle—from R&D and manufacturing to distribution—in strict accordance with Good Pharmaceutical Practices (GxP).
Disclaimer All content on pharmprom.net is for informational purposes only and does not constitute medical advice. The materials are intended exclusively for industry professionals and are not addressed to the general public.
Headlines
FMBA Files for Registration of “Allergarda,” a Recombinant Vaccine for Birch Pollen Allergy
The vaccine is currently in Phase III clinical trials, evaluating its efficacy against a placebo in patients with allergic rhinitis.
Russia Updates Pharma Licensing: New Timelines and Remote Inspections
The Russian Government has approved a new resolution updating...
GMP-Inspections of veterinary manufacturers in July – October 2025
The review provides available information on the inspection of...
Nanolek Launches Russia’s First Full-Cycle Production of Human Papillomavirus (HPV) Vaccine
The biopharmaceutical company Nanolek, with the support of the...
Newsletter
Get important news delivered directly to your inbox and stay connected!
© PHARMPROM 2026